To compare clinical outcomes, patient-reported measures (PROMs), and healthcare utilization between standard care with or without an MDCT in a cohort of women treated for breast cancer.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Disease-Free Survival (DFS)
Timeframe: 24 months (measured at 6, 12, 18, and 24 months)
Overall survival
Timeframe: 24 months (measured at 6, 12, 18, and 24 months)